Chugai Pharmaceutical Co., Ltd. CHGCF
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | 10.49% | 212.02% | -205.52% | ||
| Total Depreciation and Amortization | 9,926.69% | 173.45% | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -2,047.47% | 81.14% | 47.44% | ||
| Change in Net Operating Assets | 449.86% | -113.02% | 553.88% | ||
| Cash from Operations | 73.79% | -41.69% | 88.96% | ||
| Capital Expenditure | -66.61% | 63.57% | -28.06% | ||
| Sale of Property, Plant, and Equipment | 397.73% | -100.96% | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -233.07% | 475.52% | 55.84% | ||
| Cash from Investing | -264.77% | 297.46% | 43.43% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | 400.35% | -197.15% | 200.00% | ||
| Issuance of Common Stock | 200.00% | -63.64% | -90.43% | ||
| Repurchase of Common Stock | -200.00% | 0.00% | 0.00% | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -45,893.86% | 99.51% | ||
| Other Financing Activities | -6,774.38% | 97.03% | -7,880.39% | ||
| Cash from Financing | 98.96% | -8,155.71% | 97.27% | ||
| Foreign Exchange rate Adjustments | 127.11% | -37.15% | 392.02% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 29.79% | -154.05% | 166.56% | ||